Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Xylem Inc (NYSE: XYL) closed at $147.27 down -1.73% from its previous closing price of $149.87. In other words, the price has decreased by -$1.73 from its previous closing price. On the day, 1.71 million shares were traded. XYL stock price reached its highest trading level at $150.51 during the session, while it also had its lowest trading level at $147.13.
Ratios:
For a deeper understanding of Xylem Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 30.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 38.76. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.96. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Barclays on September 19, 2025, initiated with a Overweight rating and assigned the stock a target price of $165.
On May 30, 2025, JP Morgan started tracking the stock assigning a Overweight rating and target price of $148.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 04 ’25 when Harker Victoria D sold 1,700 shares for $148.14 per share. The transaction valued at 251,838 led to the insider holds 16,875 shares of the business.
VICTORIA HARKER bought 1,700 shares of XYL for $251,830 on Nov 04 ’25. On Oct 30 ’25, another insider, Toussaint Claudia S, who serves as the EVP, CPSO of the company, sold 10,421 shares for $152.64 each. As a result, the insider received 1,590,661 and left with 31,250 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XYL now has a Market Capitalization of 35855687680 and an Enterprise Value of 36991688704. As of this moment, Xylem’s Price-to-Earnings (P/E) ratio for their current fiscal year is 37.89, and their Forward P/E ratio for the next fiscal year is 26.41. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.03 while its Price-to-Book (P/B) ratio in mrq is 3.20. Its current Enterprise Value per Revenue stands at 4.159 whereas that against EBITDA is 19.952.
Stock Price History:
The Beta on a monthly basis for XYL is 1.17, which has changed by 0.20931184 over the last 52 weeks, in comparison to a change of 0.1476624 over the same period for the S&P500. Over the past 52 weeks, XYL has reached a high of $154.27, while it has fallen to a 52-week low of $100.47. The 50-Day Moving Average of the stock is 0.80%, while the 200-Day Moving Average is calculated to be 11.40%.
Shares Statistics:
For the past three months, XYL has traded an average of 1.18M shares per day and 1138360 over the past ten days. A total of 243.50M shares are outstanding, with a floating share count of 242.80M. Insiders hold about 0.27% of the company’s shares, while institutions hold 93.84% stake in the company. Shares short for XYL as of 1761868800 were 2972958 with a Short Ratio of 2.53, compared to 1759190400 on 2644049. Therefore, it implies a Short% of Shares Outstanding of 2972958 and a Short% of Float of 1.5599999999999998.
Dividends & Splits
According to the company, the forward annual dividend rate for XYL is 1.56, from 1.56 in the trailing year. Against a Trailing Annual Dividend Yield of 0.010409021. The stock’s 5-year Average Dividend Yield is 1.12.
Earnings Estimates
A detailed examination of Xylem Inc (XYL) is currently in progress, with 19.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $1.16, with high estimates of $1.25 and low estimates of $1.05.
Analysts are recommending an EPS of between $5.1 and $4.85 for the fiscal current year, implying an average EPS of $5.04. EPS for the following year is $5.54, with 21.0 analysts recommending between $5.72 and $5.27.
Revenue Estimates
A total of 18 analysts believe the company’s revenue will be $2.38B this quarter.It ranges from a high estimate of $2.43B to a low estimate of $2.32B. As of. The current estimate, Xylem Inc’s year-ago sales were $2.26BFor the next quarter, 18 analysts are estimating revenue of $2.18B. There is a high estimate of $2.23B for the next quarter, whereas the lowest estimate is $2.15B.
A total of 20 analysts have provided revenue estimates for XYL’s current fiscal year. The highest revenue estimate was $9.4B, while the lowest revenue estimate was $8.96B, resulting in an average revenue estimate of $9.03B. In the same quarter a year ago, actual revenue was $8.56BBased on 20 analysts’ estimates, the company’s revenue will be $9.36B in the next fiscal year. The high estimate is $9.49B and the low estimate is $9.12B.
